Zacks Research Estimates Neogen's Q4 Earnings (NASDAQ:NEOG)

Neogen Co. (NASDAQ:NEOG - Free Report) - Equities research analysts at Zacks Research cut their Q4 2025 EPS estimates for Neogen in a research report issued to clients and investors on Monday, May 5th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $0.08 per share for the quarter, down from their prior estimate of $0.09. The consensus estimate for Neogen's current full-year earnings is $0.38 per share. Zacks Research also issued estimates for Neogen's FY2026 earnings at $0.40 EPS and FY2027 earnings at $0.45 EPS.

Neogen (NASDAQ:NEOG - Get Free Report) last announced its earnings results on Wednesday, April 9th. The company reported $0.10 EPS for the quarter, missing the consensus estimate of $0.12 by ($0.02). The business had revenue of $221.00 million for the quarter, compared to the consensus estimate of $225.27 million. Neogen had a positive return on equity of 2.89% and a negative net margin of 52.12%. The firm's revenue for the quarter was down 3.4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.12 earnings per share.

Several other equities analysts have also issued reports on NEOG. Guggenheim decreased their price target on Neogen from $15.00 to $13.00 and set a "buy" rating on the stock in a research note on Thursday, April 10th. Piper Sandler cut their target price on Neogen from $6.40 to $5.00 and set a "neutral" rating on the stock in a report on Tuesday, April 22nd.

Neogen Price Performance

NASDAQ:NEOG traded down $0.02 during mid-day trading on Wednesday, reaching $5.97. The stock had a trading volume of 5,076,075 shares, compared to its average volume of 2,926,734. Neogen has a 12 month low of $3.87 and a 12 month high of $18.58. The stock has a market capitalization of $1.30 billion, a PE ratio of -2.73 and a beta of 1.83. The company has a debt-to-equity ratio of 0.33, a current ratio of 3.77 and a quick ratio of 2.46. The stock has a 50-day simple moving average of $7.10 and a two-hundred day simple moving average of $10.64.

Insiders Place Their Bets

In other Neogen news, CAO John Patrick Moylan bought 10,000 shares of the firm's stock in a transaction dated Thursday, April 10th. The stock was bought at an average cost of $5.07 per share, with a total value of $50,700.00. Following the completion of the transaction, the chief accounting officer now directly owns 10,000 shares in the company, valued at approximately $50,700. The trade was a ∞ increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Amy M. Rocklin purchased 12,500 shares of the company's stock in a transaction that occurred on Wednesday, April 23rd. The stock was acquired at an average cost of $4.99 per share, for a total transaction of $62,375.00. Following the transaction, the insider now owns 36,287 shares in the company, valued at $181,072.13. This represents a 52.55 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 67,500 shares of company stock worth $331,525. Corporate insiders own 1.13% of the company's stock.

Institutional Trading of Neogen

Hedge funds have recently bought and sold shares of the business. Harbour Investments Inc. bought a new position in Neogen during the fourth quarter valued at $27,000. Versant Capital Management Inc increased its holdings in Neogen by 1,495.4% in the 1st quarter. Versant Capital Management Inc now owns 3,127 shares of the company's stock worth $27,000 after acquiring an additional 2,931 shares during the last quarter. Blue Trust Inc. raised its stake in Neogen by 196.7% in the 4th quarter. Blue Trust Inc. now owns 3,368 shares of the company's stock valued at $41,000 after acquiring an additional 2,233 shares during the period. Johnson Financial Group Inc. purchased a new stake in Neogen during the fourth quarter valued at about $43,000. Finally, Covestor Ltd boosted its position in Neogen by 41.4% during the fourth quarter. Covestor Ltd now owns 4,103 shares of the company's stock worth $50,000 after purchasing an additional 1,202 shares during the period. 96.73% of the stock is currently owned by institutional investors.

About Neogen

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.